One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1093/annonc/mdx380.020
Copy DOI Journal: Annals of Oncology |  Publication Date: Sep 1, 2017 |
 License type: elsevier-specific: oa user license |
Affiliation: Russian Cancer Research Center NN Blokhin, Ministry of Health of the Russian Federation, Moscow City Oncology Hospital №62, St. Petersburg State Technological Institute, P.A. Hertzen Moscow Oncology Research Institute, State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care, City Clinical Oncology Center, State Research Center of the Russian Federation, St Petersburg University1317P - Multicenter observational study of the efficacy and safety of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
